BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37261323)

  • 1. Population attributable fraction of hypertension for dementia: global, regional, and national estimates for 186 countries.
    Mulligan MD; Murphy R; Reddin C; Judge C; Ferguson J; Alvarez-Iglesias A; McGrath ER; O'Donnell MJ
    EClinicalMedicine; 2023 Jun; 60():102012. PubMed ID: 37261323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population attributable fractions of modifiable risk factors for dementia: a systematic review and meta-analysis.
    Stephan BCM; Cochrane L; Kafadar AH; Brain J; Burton E; Myers B; Brayne C; Naheed A; Anstey KJ; Ashor AW; Siervo M
    Lancet Healthy Longev; 2024 Jun; 5(6):e406-e421. PubMed ID: 38824956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data.
    Mukadam N; Sommerlad A; Huntley J; Livingston G
    Lancet Glob Health; 2019 May; 7(5):e596-e603. PubMed ID: 31000129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in Population Attributable Fraction of Dementia Associated With Potentially Modifiable Risk Factors by Race and Ethnicity in the US.
    Lee M; Whitsel E; Avery C; Hughes TM; Griswold ME; Sedaghat S; Gottesman RF; Mosley TH; Heiss G; Lutsey PL
    JAMA Netw Open; 2022 Jul; 5(7):e2219672. PubMed ID: 35793088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.
    Norton S; Matthews FE; Barnes DE; Yaffe K; Brayne C
    Lancet Neurol; 2014 Aug; 13(8):788-94. PubMed ID: 25030513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population attributable fraction of modifiable risk factors for dementia in Chile.
    Vergara RC; Zitko P; Slachevsky A; San Martin C; Delgado C
    Alzheimers Dement (Amst); 2022; 14(1):e12273. PubMed ID: 35229017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially modifiable dementia risk factors in all Australians and within population groups: an analysis using cross-sectional survey data.
    See RS; Thompson F; Russell S; Quigley R; Esterman A; Harriss LR; Hyde Z; Taylor S; Radford K; LoGiudice D; McDermott R; Livingston G; Strivens E
    Lancet Public Health; 2023 Sep; 8(9):e717-e725. PubMed ID: 37633680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia occurring over a 32-year follow-up attributable to hypertension observed at different ages: Implications for dementia prevention.
    Smith JR; Sharrett AR; Pike JR; Gottesman RF; Knopman DS; Lee M; Lutsey PL; Palta P; Windham BG; Coresh J; Deal JA
    Alzheimers Dement; 2023 Aug; 19(8):3435-3447. PubMed ID: 36808817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study.
    Chen Y; Zhao J; Sun P; Cheng M; Xiong Y; Sun Z; Zhang Y; Li K; Ye Y; Shuai P; Huang H; Li X; Liu Y; Wan Z
    EClinicalMedicine; 2024 Jan; 67():102370. PubMed ID: 38130708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Feigin VL; Roth GA; Naghavi M; Parmar P; Krishnamurthi R; Chugh S; Mensah GA; Norrving B; Shiue I; Ng M; Estep K; Cercy K; Murray CJL; Forouzanfar MH;
    Lancet Neurol; 2016 Aug; 15(9):913-924. PubMed ID: 27291521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Dementia Collaborators
    Lancet Neurol; 2019 Jan; 18(1):88-106. PubMed ID: 30497964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for prevention of dementia in Denmark.
    Jørgensen K; Nielsen TR; Nielsen A; Waldemar G
    Alzheimers Dement; 2023 Oct; 19(10):4590-4598. PubMed ID: 36933232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global burden of tuberculosis attributable to cancer in 2019: Global, regional, and national estimates.
    Shen BJ; Lo WC; Lin HH
    J Microbiol Immunol Infect; 2022 Apr; 55(2):266-272. PubMed ID: 33789827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.
    Brown KF; Rumgay H; Dunlop C; Ryan M; Quartly F; Cox A; Deas A; Elliss-Brookes L; Gavin A; Hounsome L; Huws D; Ormiston-Smith N; Shelton J; White C; Parkin DM
    Br J Cancer; 2018 Apr; 118(8):1130-1141. PubMed ID: 29567982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the potential for dementia prevention through modifiable risk factors elimination in the real-world setting: a population-based study.
    Rolandi E; Zaccaria D; Vaccaro R; Abbondanza S; Pettinato L; Davin A; Guaita A
    Alzheimers Res Ther; 2020 Aug; 12(1):94. PubMed ID: 32767997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    O'Donnell MJ; Chin SL; Rangarajan S; Xavier D; Liu L; Zhang H; Rao-Melacini P; Zhang X; Pais P; Agapay S; Lopez-Jaramillo P; Damasceno A; Langhorne P; McQueen MJ; Rosengren A; Dehghan M; Hankey GJ; Dans AL; Elsayed A; Avezum A; Mondo C; Diener HC; Ryglewicz D; Czlonkowska A; Pogosova N; Weimar C; Iqbal R; Diaz R; Yusoff K; Yusufali A; Oguz A; Wang X; Penaherrera E; Lanas F; Ogah OS; Ogunniyi A; Iversen HK; Malaga G; Rumboldt Z; Oveisgharan S; Al Hussain F; Magazi D; Nilanont Y; Ferguson J; Pare G; Yusuf S;
    Lancet; 2016 Aug; 388(10046):761-75. PubMed ID: 27431356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of Vision Impairment to a Life-Course Model of Potentially Modifiable Dementia Risk Factors in the US.
    Ehrlich JR; Goldstein J; Swenor BK; Whitson H; Langa KM; Veliz P
    JAMA Neurol; 2022 Jun; 79(6):623-626. PubMed ID: 35467745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Burden of Dementia due to Down Syndrome, Parkinson's Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Dementia Collaborators
    Neuroepidemiology; 2021; 55(4):286-296. PubMed ID: 34182555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis.
    Noubiap JJ; Nansseu JR; Lontchi-Yimagou E; Nkeck JR; Nyaga UF; Ngouo AT; Tounouga DN; Tianyi FL; Foka AJ; Ndoadoumgue AL; Bigna JJ
    Lancet Child Adolesc Health; 2022 Mar; 6(3):158-170. PubMed ID: 35051409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.